UPDATE : Friday, December 13, 2019
상단여백
Regulator OKs Jeil's advanced colorectal cancer treatment by Lee Han-soo 2019-10-21 11:38
Ministry OKs ATGC's p1, 2 trial for BTX by Lee Han-soo 2019-10-18 18:23
Physicians feel burdened by Ranitidine ban: survey by Lee Han-soo 2019-10-18 16:48
Daewoong launches BTX in Canada by Lee Han-soo 2019-10-18 14:31
CHA Biotech wins patent for somatic-cloned embryonic stem cell tech by Lee Han-soo 2019-10-17 17:59
라인
US sales of Remicade drop due to biosimilar’s rise by Jeong Sae-im 2019-10-17 13:32
'Eisai's Lenvima extends survival period, improves patients’ quality of life' by Lee Han-soo 2019-10-16 18:22
‘New drug approval process takes about 300 days in Korea’ by Lee Han-soo 2019-10-16 15:06
Merck Korea forcefully shuts down general medicine biz by Kim Yun-mi 2019-10-15 15:51
Galderma Korea’s key strategy: choice and concentration by Kim Yun-mi 2019-10-15 13:56
라인
Medytox, Daewoong still in dispute over Nabota's spore appraisal by Lee Han-soo 2019-10-15 11:28
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients by Lee Han-soo 2019-10-14 18:01
HanAll's Chinese partner ends P2 trial of dry eye treatment by Lee Han-soo 2019-10-14 14:08
[Special] How are Korean employees coping with big-pharma M&As? by Kim Yun-mi 2019-10-14 13:45
Sanofi releases data showing improved survival for prostate cancer treatment by Lee Han-soo 2019-10-14 12:16
라인
Regulator keeps Kolon Tissuegene listed with 1-year grace period by Lee Han-soo 2019-10-12 09:41
GC to market Merck's diabetes treatment by Lee Han-soo 2019-10-11 18:13
Bayer drugs out of stock in Korea by Lee Han-soo 2019-10-11 16:36
Sanofi to cover part of Dupixent cost for atopic dermatitis patients by Kim Yun-mi 2019-10-11 15:13
Takeda Korea’s labor union goes on strike by Lee Han-soo 2019-10-11 14:33
여백
여백
여백
Back to Top